Deep learning-driven drug response prediction and mechanistic insights in cancer genomics
Abstract In the field of cancer therapy, the diversity and heterogeneity of cancer genomes in clinical patients complicate and challenge the effective use of non-targeted drugs, as these drugs often fail to address specific genetic events. Recent advancements in large-scale in vitro drug screening a...
Saved in:
| Main Authors: | Guili Yu, Qiangqiang Fan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-91571-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Pharmacogenomics for improving drug safety and efficacy in cancer
by: Zhiyao He, et al.
Published: (2025-07-01) -
Phenoconversion of CYP3A4, CYP2C19 and CYP2D6 in Pediatrics, Adolescents and Young Adults With Lymphoma: Rationale and Design of the PEGASUS Study
by: Rachel Conyers, et al.
Published: (2025-04-01) -
Profiling genetic mutations in the DNA damage repair genes of oral squamous cell carcinoma patients from Pakistan
by: Wafa Naeem, et al.
Published: (2025-03-01) -
BEYOND TRADITIONAL DENTISTRY: THE RISE OF GENOMIC AND PERSONALIZED ORAL HEALTH
by: Laurenţiu-Camil Bohîlţea, et al.
Published: (2025-03-01) -
Identifying factors related to sertraline concentrations in child/adolescent and adult patients: insights from a therapeutic drug monitoring service
by: Ruoming Li, et al.
Published: (2025-06-01)